CNBC
Search documents
Apple isn't playing the same AI capex game as the rest of the megacaps
CNBC· 2025-10-30 23:37
Core Insights - Apple is adopting a hybrid approach to AI, utilizing both its own chips and external computing capacity, contrasting with competitors who are heavily investing in AI infrastructure [1][2][4] - The company reported a significant increase in capital expenditures, up 35% year-over-year to $12.72 billion, with expectations to rise further to $14.3 billion [4][5] - Despite a different strategy in AI, Apple continues to see strong consumer demand for its products, particularly the iPhone 17, with projected sales growth of 10% to 12% in the upcoming quarter [7][8] Capital Expenditures - Apple spent $12.72 billion on capital expenditures in fiscal 2025, which is a 35% increase from the previous year [4][5] - Analysts predict that Apple's capital expenditures will increase to $14.3 billion this year [5] - The spending is primarily associated with building out the Private Cloud Compute environment in Apple's data centers [5] AI Strategy - Apple is focusing on its own chips for AI services, rather than relying on Nvidia or AMD [2] - The company has launched Apple Intelligence, a suite of AI tools, although it has received mixed reviews and some features have been delayed [6] - Apple's hybrid model allows some AI-related spending to be classified as operating expenses, contributing to an 11% rise in operating expenses to $15.91 billion [9] Market Response - Consumer response to the iPhone 17 models has been exceptionally positive, with CEO Tim Cook noting it was "off the chart" [7] - Apple executives believe that AI features will increasingly influence smartphone purchasing decisions [8]
Tech stocks' Thursday declines might not last long, Jim Cramer says
CNBC· 2025-10-30 22:28
Core Insights - Despite a dip in tech stocks, there is optimism for a rebound due to strong quarterly performances from Apple and Amazon [1] - Meta's earnings report caused market weakness, particularly due to increased spending on artificial intelligence, leading to a significant drop in its stock [2] - Apple and Amazon reported positive earnings, with Apple expecting growth in China and Amazon's AWS division showing accelerated revenue growth [3][4] Group 1: Market Performance - The S&P 500 declined by 0.99%, the Dow Jones Industrial Average lost 0.23%, and the Nasdaq Composite dipped by 1.58% during the session [1] - Meta's stock experienced its largest one-day loss since 2022, dropping more than 11% [2] Group 2: Company Earnings - Meta's capital expenditure guidance increased to between $70 billion and $72 billion, up from $66 billion to $72 billion [2] - Apple provided positive revenue guidance, with CEO Tim Cook anticipating growth in China during the current quarter [3] - Amazon reported a significant top and bottom line beat, with AWS revenue growth accelerating from 17.5% to 20.2% [4]
Palantir communications chief calls the company's political shift 'concerning'
CNBC· 2025-10-30 21:53
Core Viewpoint - Palantir Technologies is experiencing a political shift towards the Trump administration, which is raising concerns among its leadership, particularly regarding the company's previous bipartisan approach [1][2]. Group 1: Company Leadership and Political Stance - Lisa Gordon, Palantir's head of global communications, expressed concern over the company's political direction, indicating a shift towards pro-Trump sentiments [1]. - Gordon, a Democrat with a history of working on political campaigns, noted that the company has historically maintained a balance between Republican and Democratic affiliations, but is now facing challenges due to this shift [2]. - CEO Alex Karp's recent political contributions and support for Donald Trump reflect a significant change in the company's political alignment, which has been influenced by his frustrations with the Democratic party [3].
Coinbase shares rise on third-quarter earnings beat
CNBC· 2025-10-30 20:42
Core Insights - Coinbase reported strong financial results for Q3, with net income rising to $432.6 million, or $1.50 per share, compared to $75.5 million, or 28 cents per share, a year ago, exceeding Wall Street expectations [1] - Revenue for the quarter increased to $1.87 billion from $1.21 billion year-over-year, surpassing analysts' expectations of $1.8 billion [1] - Transaction-related revenue saw a significant increase of 37% quarter-over-quarter, reaching $1 billion [2]
Apple sees big December quarter driven by strong iPhone 17 demand
CNBC· 2025-10-30 20:35
Core Insights - Apple is set to report its fiscal fourth quarter earnings, which includes initial sales data for the new iPhone 17 models [1] - Analysts indicate improved demand for iPhone 17, particularly for entry-level and Pro models, with expectations for sales growth in fiscal 2025 [2] Financial Performance - In the June quarter, Apple reported a 10% year-over-year revenue growth, while analysts expect a 7.7% sales growth for the September quarter [6] - Analysts project Apple to guide for $132.31 billion in December quarter sales and earnings of $2.53 per share, compared to an EPS of $1.77 and revenue of $102.24 billion in the previous quarter [6] Tariff Impact and Capital Expenditure - Apple has faced negative impacts from tariffs, with potential costs of $1.1 billion, and investors are keen to see if actual costs were below forecasts [3][4] - There is a call for Apple to increase capital expenditure and AI investments, as it has not participated significantly in the data center and AI chip investment boom [4] AI and Technology Investments - Apple has indicated a significant increase in investments in technology, which is expected to reflect in capital expenditures, with insights on AI strategy anticipated from CEO Tim Cook [5] - The company is also shipping AI servers from a factory in Houston, indicating a move towards enhancing its AI capabilities [3] Sports and Media Strategy - Apple has secured a five-year deal with Formula 1 to broadcast races in the U.S. on Apple TV, which is part of its broader sports and media strategy [5]
Netflix announces a 10-for-1 stock split
CNBC· 2025-10-30 20:18
Core Points - Netflix announced a 10-for-1 stock split to make shares more accessible to retail investors and employees [1][2] - Shareholders as of November 10 will receive nine additional shares for each share held on November 14, with trading at the new price starting on November 17 [1] - The stock split comes after a significant increase in share price, with Netflix shares exceeding $1,000 each [2]
Amazon soars 10% as earnings beat estimates, company posts strong cloud growth
CNBC· 2025-10-30 20:10
Core Insights - Amazon is set to release its third-quarter results, with a focus on AWS growth amid increasing competition from Google and Microsoft [1][2] - AWS is projected to grow 18.1% year-over-year, maintaining the same growth rate as the previous quarter, while competitors Google Cloud and Microsoft Azure reported significantly higher growth rates of 34% and 40% respectively [2] - The company is facing challenges in the perception of missing out on lucrative AI cloud service deals, as competitors secure substantial partnerships [3][4] Financial Performance - Expected earnings per share for Amazon are $1.57, with total revenue projected at $177.8 billion [5] - AWS revenue is anticipated to be $32.42 billion, while advertising revenue is expected to reach $17.34 billion [5] Competitive Landscape - AWS recently experienced a significant outage lasting over 15 hours, impacting numerous websites, which raises concerns about reliability compared to competitors [2] - Amazon has launched Project Rainier, an $11 billion AI data center aimed at enhancing its capabilities in AI, particularly in collaboration with Anthropic [4] - CEO Andy Jassy emphasized AWS's strong market position but acknowledged the early stage of the AI industry, which is currently dominated by a few large models [5]
Reddit just reported third-quarter earnings that beat on sales
CNBC· 2025-10-30 20:08
Core Insights - Reddit's third-quarter earnings exceeded expectations, with significant revenue growth and net income increase, but user growth for logged-in users showed signs of slowing down [1][4]. User Growth - Global daily active uniques grew 19% year-over-year to 116 million, surpassing analyst estimates of 114 million [1]. - Logged-in DAUq in the U.S. rose 7% year-over-year to 23.1 million, a slowdown from the 12% growth in the previous quarter [2]. - Global logged-in DAUq increased 14% year-over-year to 50.2 million, while logged-out DAUq jumped 24% to 65.8 million [2]. Financial Performance - Sales surged 68% year-over-year in the third quarter, with net income reaching $163 million, a 23% increase from $133 million in the same period last year [4]. - The company expects fourth-quarter sales between $655 million and $665 million, exceeding Wall Street's expectation of $638 million [4]. - Adjusted earnings for the fourth quarter are projected to be between $275 million and $285 million, surpassing projections of $259 million [5]. Revenue Metrics - Third-quarter global average revenue per user was $5.04, exceeding analyst estimates of $4.82 [5]. - Revenue in the U.S. was $480 million, surpassing expectations of $445 million, while international sales reached $105 million, ahead of the projected $104 million [5]. - The "Other revenue" category, including data licensing, rose 7% year-over-year to $36 million [6]. Earnings Summary - Earnings per share were reported at 80 cents, compared to the expected 51 cents [7]. - Total revenue for the quarter was $585 million, exceeding the expected $546 million [7].
Amazon cloud records 20% sales growth, topping estimates
CNBC· 2025-10-30 20:07
Core Insights - Amazon's cloud computing revenue increased by 20% in Q3, reaching $33 billion, surpassing analysts' expectations of $32.42 billion, which represented a growth of 18.1% [1] - AWS faces increasing competition from Google and Microsoft, with Google reporting a 34% revenue increase and Microsoft Azure achieving 40% growth in the same quarter [2] - AWS recently experienced a significant outage lasting over 15 hours, impacting numerous websites, while Microsoft also faced outages shortly before its earnings release [3] Investment and Strategic Developments - Amazon launched its $11 billion AI data center, Project Rainier, aimed at training models for Anthropic, a startup in which Amazon has invested $8 billion [4] - The new data center is expected to enhance Amazon's position in the competitive AI cloud services market, especially as Anthropic plans to utilize 1 million of Amazon's custom Trainium2 chips by the end of 2025 [4] - Amazon's efforts to strengthen its AI capabilities come in response to significant cloud partnerships formed by competitors, including a multi-billion dollar deal between Anthropic and Google, as well as substantial agreements between Meta and other cloud providers [5]
Shares of breast cancer therapy developer Olema Pharmaceutical could more than double from here
CNBC· 2025-10-30 19:25
Core Insights - The clinical-stage biopharmaceutical company has seen its shares increase by approximately 50% this year and over 70% in the last three months, with analysts projecting a potential upside of 164% based on an average price target of $23.71 per share [1][2]. Company Developments - The company announced promising clinical data for its lead candidate, palazestrant, which is an oral medication being evaluated for estrogen receptor-positive (ER+) breast cancer [2]. - Investors are optimistic about palazestrant ahead of a key clinical trial's primary readout expected in the second half of 2026, which could lead to FDA submission and commercialization [2]. Drug Mechanism and Comparison - Palazestrant is designed to completely shut off the estrogen receptor, potentially delaying tumor growth and maintaining disease stability for longer periods [4]. - The drug is part of the same therapeutic family as tamoxifen, but unlike tamoxifen, palazestrant does not have an agonist effect, meaning it does not trigger physiological responses elsewhere in the body [3]. - The company aims to improve targeting of the estrogen receptor, which is a validated molecular target in cancer, to provide better therapy for breast cancer patients, focusing on the approximately 70% of patients diagnosed with ER-positive or two-negative breast cancer [5].